Valeant Pharmaceuticals International Strategic Accounts Manager Salaries in Lansing, MI
The average Valeant Pharmaceuticals International Strategic Accounts Manager in Lansing, MI earns an estimated $129,600 annually. Valeant Pharmaceuticals International's Strategic Accounts Manager compensation is $14,551,735 less than the US average for a Strategic Accounts Manager.
In Lansing, MI, The Business Development Department at Valeant Pharmaceuticals International earns $1,202 more on average than the Engineering Department.
Last updated 2 years ago.
- $129,600
- avg. base
Strategic Accounts Manager Salaries at Valeant Pharmaceuticals International
In Lansing, MI, Strategic Accounts Managers earn $17,241 more than Account Managers, and $25,967 less than Business Development Managers.
Compensation at Valeant Pharmaceuticals International by Department
In Lansing, MI, The Business Development Department averages $1,202 more than the Engineering Department, and $14,009 less than the Legal Department
Strategic Accounts Manager Compensation by Gender (All Companies)
The average female Strategic Accounts Manager at companies similar size to Valeant Pharmaceuticals International reported making $145,283, while the average male Strategic Accounts Manager at similar sized companies reported making $176,168.
Strategic Accounts Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Strategic Accounts Manager at companies similar size to Valeant Pharmaceuticals International reported making $169,167, while the average Hispanic or Latino Strategic Accounts Manager at similar sized companies reported making $110,000.
How Strategic Accounts Managers at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Strategic Accounts Managers at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Strategic Accounts Managers at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
